Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial. [electronic resource]
Producer: 20170713Description: 344-52 p. digitalISSN:- 1532-6535
- Adult
- Antidepressive Agents, Second-Generation -- adverse effects
- Bupropion -- adverse effects
- Double-Blind Method
- Drug Therapy, Combination -- adverse effects
- Female
- Humans
- Male
- Naltrexone -- adverse effects
- Narcotic Antagonists -- adverse effects
- Patient Compliance
- Smoking -- drug therapy
- Smoking Cessation -- methods
- Substance Withdrawal Syndrome -- drug therapy
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.